JLK, Inc. (KOSDAQ:322510)

Market Cap	107.51B -41.5%
Revenue (ttm)	3.27B +83.9%
Net Income	-14.21B
EPS	-561.83
Shares Out	25.39M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	267,645
Open	4,185.00
Previous Close	4,235.00
Day's Range	4,020.00 - 4,235.00
52-Week Range	3,965.00 - 9,210.00
Beta	1.53
Analysts	n/a
Price Target	n/a
Earnings Date	May 27, 2026

About JLK, Inc.

JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer’s disease; and in lung diseases, ...

• Industry: Conglomerates
• Sector: Industrials
• Founded: 2014
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 322510

Financial Performance

In 2025, JLK, Inc.'s revenue was 3.34 billion, an increase of 133.94% compared to the previous year's 1.43 billion. Losses were -13.61 billion, 1.13% more than in 2024.